PerkinElmer
check quantity

XenoLight RediJect Chemiluminescent Inflammation Probe (Standard kit)

XenoLight RediJect Inflammation probe is a chemiluminescent in vivo reagent for monitoring Inflammation. This probe is offered in a ready-to-use format and can be conveniently applied to study myeloperoxidase (MPO) activity of activated phagocytes.

You successfully added item(s) to your cart

For laboratory use only. This product is intended for animal research only and not for use in humans.

Part Number
List Price
Your Price
Quantity
760536
333.00 GBP
more
Buy Now

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Detail Information

The RediJect Inflammation Probe will allow for longitudinal tracking of MPO level and inflammation status, in vivo, in a variety of disease models, including rheumatoid arthritis, acute septic shock, contact hypersensitivity reaction, and neutrophil rich cancers.

  • Novel ready-to-use probe to monitor phagocyte mediated inflammation non-invasively 
  • Dispensed to image 20 animals (standard kit) 
  • Includes a fluorescent tracer to validate substrate injection 
  • Improved sensitivity due to the chemiluminescent read-out 
  • In vivo imaging quality, validated on IVIS imaging systems

For laboratory use only. This product is intended for animal research only and not for use in humans.

Specifications

Optical Imaging Classification Chemiluminescence Imaging
Product Brand Name XenoLight
Quantity in a Package Amount 20.0 Units
Shipping Condition Blue Ice
Therapeutic Area Arthritis, Inflammation
Unit Size 1 Kit (20 animals)
Resources, Events & More
  • All

Brochure

XenoLight RediJect Inflammation Probe (Product Sheet)

XenoLight RediJect Inflammation Probe is a chemiluminescent reagent for monitoring inflammation. This probe is offered in a ready-to-use format and can be conveniently applied to study myeloperoxidase (MPO) activity of activated phagocytes. The RediJect Inflammation Probe will allow for longitudinal tracking of MPO level and inflammation status, in vivo, in a variety of disease models. This probe has been validated in vivo in detecting rheumatoid arthritis and contact hypersensitivity. Given the probe’s peak emission is 425 nm, the signal is significantly attenuated when imaging at depth, posing challenges for detecting inflammation in deep tissues.

PDF 1 MB